<DOC>
	<DOCNO>NCT00399204</DOCNO>
	<brief_summary>The study aim see significant difference cardiovascular outcome type 2 diabetes patient treat pioglitazone Metformin</brief_summary>
	<brief_title>Comparison Cardiovascular Outcomes Pioglitazone Metformin Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Newly diagnose ( less six month since diagnosis control dietary modification ) type 2 diabetic patient sex age 2560 year . 2 . Ready give write informed consent 1 . Presence ketonuria 2 . Severe concurrent , infection illness 3 . History hypersensitivity study drug 4 . Impaired renal function 5 . Pulmonary insufficiency hypoxemia 6 . Severe hepatic disease 7 . Congestive heart failure 8 . History myocardial infarction angina ( stable/unstable ) 9 . History alcohol drug abuse 10 . Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>